Search Results for "Psa Increased After Negative Biopsy"

08:08 EDT 28th October 2016 | BioPortfolio

Matching Channels

Matching News

Liquid biopsy assay exhibits efficacy similar to traditional tumor biopsy

CHICAGO — Liquid biopsy identified genomic alterations in patients with advanced solid tumors at a similar rate to traditional tumor biopsy, according to data presented at the ASCO Annual Meeting.In...

Saturday at ASCO: Liquid Biopsy Matches Tissue Biopsy

The results from a 'liquid biopsy' measuring circulating tumor DNA in blood matched up to these from conventional tissue biopsies. Medscape Medical News

Precision Biopsy expands clinical trial of ClariCore biopsy system to include prostate cancer patients

Precision Biopsy announced that its application for an Investigational Device Exemption (IDE) was approved by the U.S. Food and Drug Administration (FDA), allowing the company to expand its clinical t...

Prostate Cancer: Informed Decisions or Information Overload?

(MedPage Today) -- To biopsy, or not to biopsy -- a Shakespearean dilemma

ASCO 2016: Liquid biopsy may help guide treatment decisions for advanced solid tumours

A large-scale genomic analysis finds that patterns of genetic changes detected in blood samples (liquid biopsy) closely mirror those identified in traditional tumour biopsy. With blood samples from m...

Biopsy Combo Boosts Esophageal Cancer Detection (CME/CE)

(MedPage Today) -- Brush plus standard biopsy shows promise in Barrett's esophagus

PCa Diagnosis by MR/Ultrasound Fusion-Guided Biopsy

Which biopsy is more efficient in men with MR-visible prostate lesions? Targeted or standard? Journal of the National Cancer Institute

Roche Eyes Liquid Biopsy As A Boost To Drug Development, Cancer Monitoring

Roche Molecular Diagnostic's top researcher, Walter Koch, discusses the promise of liquid biopsy following FDA's recent approval of its first liquid-biopsy companion diagnostic, Roche's cobas test for...

Matching PubMed Articles

Management of men with previous negative prostate biopsy.

Up to 70% of prostate biopsies are negative in men with suspected prostate cancer. Because of inherent limitations in biopsy strategies, a significant proportion of cancers are missed on initial biops...

Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results.

The purpose of this study was to evaluate the prostate cancer yield rate of targeted transrectal ultrasound (TRUS)-guided biopsy with cognitive magnetic resonance imaging (MRI) registration without co...

Predictive Value of Negative 3T Multiparametric Prostate MRI on 12 Core Biopsy Results.

To evaluate the cancer detection rates (CDR) for men undergoing 12 core systematic prostate biopsy with negative prebiopsy mpMRI (NegMR).

Multiple biopsy passes and the risk of complications of percutaneous liver biopsy.

To minimize the sample variability of liver biopsy, the tissue length should be at least 25 mm. Consequently, more than one biopsy pass is needed with cutting biopsy needles. We aimed to investigate...

Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan.

Sentinel lymph node (SLN) biopsy is now accepted as the standard of care for axillary staging in women with node-negative breast cancer. Currently, dye, radioisotope (RI), and fluorescence indocyanine...

Search Whole site using Google

Quick Search
Advertisement Advertisement